Skip to main content

Table 2 SGLT-2i prescriptions in type 2 diabetes according to renal function (eGFR) categories

From: Prescribing sodium-glucose co-transporter-2 inhibitors for type 2 diabetes in primary care: influence of renal function and heart failure diagnosis

eGFR categorya

Prescribed SGLT-2i

(N = 26,700)

 < 45

56 (0.2)

45–59

407 (1.5)

 ≥ 60

24,895 (93.2)

Missing

1342 (5.0)

  1. Data are presented as n (%)
  2. eGFR estimated glomerular filtration rate, SGLT-2i sodium–glucose co‐transporter‐2 inhibitor
  3. aeGFR closest to first SGLT-2i prescription
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840